Godsland Ian F, Bruce Raymond, Jeffs James A R, Leyva Francisco, Walton Christopher, Stevenson John C
Faculty of Medicine, Endocrinology and Metabolic Medicine, Imperial College London, London, UK.
Int J Cardiol. 2004 Dec;97(3):543-50. doi: 10.1016/j.ijcard.2004.05.008.
To evaluate prediction of coronary heart disease (CHD) by quantitative measures of the metabolic syndrome and inflammation in a cohort of high socio-economic status males.
Incident CHD was identified in a cohort of 649 male participants in a company health programme during a mean follow-up of 10.6 years. Using factor analysis, metabolic syndrome and sub-clinical inflammation scores were derived from baseline measurements, which included an oral glucose tolerance test-derived measure of insulin resistance. Factor scores were then included as predictor variables in a Cox regression analysis of incident CHD.
Forty-two cases of definite CHD were identified on follow-up. The conventional risk factors, cigarette smoking, blood pressure, total cholesterol and low HDL cholesterol were clearly distinguished as significant predictors of incident CHD. Erythrocyte sedimentation rate was also an independent predictor (coefficient 0.0480, z score 2.39, p=0.017). The metabolic syndrome factor included insulin resistance, body mass index, serum triglycerides, glucose tolerance, serum uric acid and fasting plasma glucose. The inflammation factor included serum globulin, blood leukocyte count, low albumin, haemoglobin and cholesterol, but not erythrocyte sedimentation rate. The inflammation factor score was a significant predictor of CHD (coefficient 0.4601, z score 2.43, p=0.015) but the metabolic syndrome factor was not (coefficient 0.2488, z score 1.24, p=0.2).
Erythrocyte sedimentation rate and a factor analysis-derived measure of sub-clinical inflammation were important in the development of CHD in this relatively low-risk group, but neither metabolic syndrome factor score nor its individual components predicted CHD.
通过对一组社会经济地位较高的男性进行代谢综合征和炎症的定量测量,评估冠心病(CHD)的预测情况。
在一项公司健康计划的649名男性参与者队列中,经过平均10.6年的随访确定了新发冠心病病例。使用因子分析,从基线测量中得出代谢综合征和亚临床炎症评分,其中包括口服葡萄糖耐量试验得出的胰岛素抵抗测量值。然后将因子得分作为新发冠心病Cox回归分析中的预测变量。
随访中确定了42例确诊冠心病病例。传统危险因素,即吸烟、血压、总胆固醇和低高密度脂蛋白胆固醇,被明确区分为新发冠心病的显著预测因素。红细胞沉降率也是一个独立预测因素(系数0.0480,z值2.39,p = 0.017)。代谢综合征因子包括胰岛素抵抗、体重指数、血清甘油三酯、糖耐量、血清尿酸和空腹血糖。炎症因子包括血清球蛋白、血白细胞计数、低白蛋白、血红蛋白和胆固醇,但不包括红细胞沉降率。炎症因子得分是冠心病的显著预测因素(系数0.4601,z值2.43,p = 0.015),但代谢综合征因子不是(系数0.2488,z值1.24,p = 0.2)。
在这个相对低风险组中,红细胞沉降率和因子分析得出的亚临床炎症测量值在冠心病的发生中很重要,但代谢综合征因子得分及其单个成分均不能预测冠心病。